Home/Animate Biosciences/Jonathan Wolfson
JW

Jonathan Wolfson

Co-Founder & Executive Chairman

Animate Biosciences

Animate Biosciences Pipeline

DrugIndicationPhase
Pulmonary ProgramLikely fibrotic lung disease (e.g., IPF)Preclinical
Dermatology ProgramLikely pathological scarring or chronic woundsPreclinical
Cardiac ProgramLikely cardiac fibrosis/heart failurePreclinical
Hepatic ProgramLikely liver fibrosis/cirrhosisPreclinical